Stay updated with breaking news from Bihua Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Friday, Helix Acquisition Corp. II Class A Ordinary Shares (HLXB) announced the pricing of its upsized initial public offering of 16 million Class A ordinary shares at $10 per share.
At least not to the folks at Cormorant Asset Management. Last week, the life sciences and biopharma specialist filed plans to raise $100 million for Helix…
By Stephen Nakrosis Blank check company Helix Acquisition Corp. II filed for a $100 million initial public offering on Thursday. The company said its sponsor...
Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) were up 2% on Friday . The stock traded as high as $63.13 and last traded at $62.70. Approximately 113,153 shares changed hands during trading, a decline of 78% from the average daily volume of 526,207 shares. The stock had previously closed at $61.48. Analysts Set […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)’s share price gapped up prior to trading on Friday . The stock had previously closed at $55.25, but opened at $56.50. MoonLake Immunotherapeutics shares last traded at $55.60, with a volume of 12,281 shares changing hands. Analyst Ratings Changes Several research firms recently commented on MLTX. Bryan, Garnier […]